Risk and Prevention

Patients can have multiple risk factors for developing neutropenia, including type of chemotherapy or radiation, doses, and administration schedule of the treatment regimen.
"Care of Patients With Neutropenia," available as a journal article and podcast, summarizes caring for patients experiencing chemotherapy-induced neutropenia.
From prevention and identification of risk status to the development and use of targeted therapies, genetics is changing the face of oncology care. ONS offers many resources for nurses to learn more about genetics (the study of individual genes) and genomics (the study of all genes in the human genome).
This 13-minute slideshow reviews patient- and treatment-related factors that influence an individual’s risk for chemotherapy-induced nausea and vomiting (CINV).
Evidence is strong that exercise in general promotes and enhances health (Fentem, 1994). Additional studies support the concept that exercise may play a protective role in the development of cancer in some populations.
For the most current and comprehensive information on cancer genetics and human genomic discoveries, check out the following organizations and resources.